May 10, 2006 | The acquisitions of GlycoFi, based in Lebanon, N.H., and Abmaxis, based in Santa Clara, Calif., are both expected to close by the end of June. The purchase announcements came two weeks after the company’s chief executive, Richard T. Clark, promised shareholders big changes to Merck, which has been wounded in litigation over heart problems caused by its pain medication Vioxx.
Merck Loses Appeals Court Ruling Over Vioxx Class-Action Case
March 31 (Bloomberg) -- Merck & Co. must defend a group lawsuit filed by health maintenance organizations, insurers, and unions claiming that the company misrepresented the safety of its Vioxx painkiller, a New Jersey appeals court panel ruled. More...Return Vioxx to market, experts tell Health Canada
The anti-inflammatory drug Vioxx should be allowed back onto the market in Canada although it increases the risk of heart attack and stroke, an expert panel recommended on Thursday.
Merck reaches settlement for $4.85 billion over Vioxx
TRENTON, N.J. - Merck & Co. said Friday it will pay $4.85 billion to end thousands of state and federal lawsuits over its painkiller Vioxx in one of the largest drug settlements ever.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved